<DOC>
	<DOCNO>NCT00834496</DOCNO>
	<brief_summary>Sirolimus safely switch early 90 day liver transplantation excellent tolerability amelioration calcineurin inhibitor toxicity initiate switch .</brief_summary>
	<brief_title>Switching From One Type Anti-rejection Drug ( Tacrolimus Cyclosporine ) Another ( Sirolimus ) Approximately 90-180 Days After Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Adult ( 18 year old ) patient undergo liver transplantation Thomas Jefferson University Hospital . 2 . Diagnosed least one follow CNI side effect 90180 day post transplantation : 1 . CNI renal toxicity . Any liver transplant recipient elevate creatinine level ( great 1.4 mg/dl ) impair creatinine clearance ( MDRD ) 4060 ml/minute decrease 15 % compare baseline set therapeutic CNI level , without suspicion acute chronic allograft rejection . 2 . Hepatic fibrosis biopsy . Any patient fibrosis see liver biopsy LFT 's 2 time upper normal limit . 3 . CNI neurologic toxicity . Any patient significant neurological side effect CNIs . This include follow : seizure secondary epileptogenic focus metabolic derangement ; alteration speech range aphasia slur speech ; inability awake alert . 4 . Post transplant diabetes . Any patient develop diabetes transplant CNIs think contribute poor glycemic control . 3 . Signed informed consent approximately 90 180 day post transplantation . 1 . Invasive/surgical therapy within 2 week 90180 day post transplantation conversion . ( e.g . patient Ttubes would eligible study Ttube removal coincide conversion date ) . 2 . Open surgical wound 90180 day post transplantation . 3 . Acute cellular rejection first 90180 day post transplantation . 4 . Retransplants multipleorgan transplant . 5 . Active infection . 6 . Pregnancy . 7 . Malignancy within 3 year prior liver transplantation ( except adequately treat basal cell carcinoma ) . Patients HCC prior transplant exclude . 8 . Total cholesterol &gt; 300 mg/dl medical treatment triglyceride &gt; 150 mg/dl 90180 day post transplantation . 9 . White blood cell count &lt; 3,000/mm3 platelet count &lt; 100,000/mm3 90180 day post transplantation . 10 . Ascites . 11 . Patients chemotherapy . 12 . Urine protein/creatinine ration &gt; 0.5</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>